Manuel Sanchez-Felix

Company: Halozyme Therapeutics

Job title: Vice President, Drug Delivery

Seminars:

Delivering Orally Bioavailable Peptides with Increased Stability & Half-Life Through Formulation Innovation 11:30 am

Collaborating with formulation teams to learn how to optimize formulation for peptides of different sizes • Discussing biopharmaceutics mechanisms for different oral formulation platforms Translating formulation considerations into early-stage design of peptides with clinical viability potential Sharing key learnings from the successful launch of oral semaglutide and continued success of subcutaneous peptide products Read more

day: Conference Day Two